Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines is seeking an Associate Director, Clinical Pharmacology to join the Nonclinical Development and Clinical Pharmacology (NDCP) Organization. The successful candidate will provide strategic insight and technical leadership within the Clinical Pharmacology function, author technical reports, and participate in regulatory interactions.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines